glp 1 candidates GLP-1 Weight Loss Candidates: Clinical Eligibility & Biomarkers – PlexusDx Nutritional priorities to support GLP-1
Description
PMID 40507553
The doses used were standard doses
The independent and combined hepatic effects of GIP and GLP-1 have been explored in preclinical studies and potential beneficial effects on NAFLD/NASH have been demonstrated [6, 62,63,64,65,66]
When you aim to achieve the same periodic average as the 7-day dosing, with the shorter period, each dose needs to be around 55%-60% of the normal 7-day dose
Medications that have boxed warnings can be effective treatment options in some cases, but there are potential complications to consider before starting treatment
The FDA allows bulk compounding of prescription medications, which are in shortage, and many Americans are now taking compounded GLP-1 medications
